Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients.

MLA

Caillard, Sophie, et al. “Insights from the BKEVER Trial Comparing Everolimus versus Mycophenolate Mofetil for BK Polyomavirus Infection in Kidney Transplant Recipients.” Kidney International, Oct. 2024. EBSCOhost, https://doi.org/10.1016/j.kint.2024.09.018.

APA

Caillard, S., Meyer, N., Solis, M., Bertrand, D., Jaureguy, M., Anglicheau, D., Ecotiere, L., Buchler, M., Bouvier, N., Schvartz, B., Rerolle, J. P., Heng, A. E., Couzi, L., Duveau, A., Morelon, E., LeMeur, Y., Golbin, L., Thervet, E., Benotmane, I., & Fafi-Kremer, S. (2024). Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney transplant recipients. Kidney International. https://doi.org/10.1016/j.kint.2024.09.018

Chicago

Caillard, Sophie, Nicolas Meyer, Morgane Solis, Dominique Bertrand, Maite Jaureguy, Dany Anglicheau, Laure Ecotiere, et al. 2024. “Insights from the BKEVER Trial Comparing Everolimus versus Mycophenolate Mofetil for BK Polyomavirus Infection in Kidney Transplant Recipients.” Kidney International, October. doi:10.1016/j.kint.2024.09.018.